Elanco Animal Health Inc (ELAN) NPV

Sell:$11.50Buy:$11.51$0.22 (1.88%)

Prices delayed by at least 15 minutes
Sell:$11.50
Buy:$11.51
Change:$0.22 (1.88%)
Deal now
Prices delayed by at least 15 minutes
Sell:$11.50
Buy:$11.51
Change:$0.22 (1.88%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Key people

Jeffrey N. Simmons
President, Chief Executive Officer, Director
Todd S. Young
Chief Financial Officer, Executive Vice President
Shiv O'Neill
Executive Vice President, General Counsel, Company Secretary
David S. Kinard
Executive Vice President, Human Resources, Corporate Communications and Administration
Timothy J. Bettington
Executive Vice President - Corporate Strategy and Market Development
Ramiro M. Cabral
Executive Vice President , President of Elanco International
Ellen de Brabander
Executive Vice President - Innovation and Regulatory Affairs
Grace Mcardle
Executive Vice President - Manufacturing and Quality
Rajeev Modi
Executive Vice President - U.S. Pet Health and Global Digital Transformation
Jose Manuel Correia de Simas
Executive Vice President - U.S. Farm Animal Business
Lawrence Erik Kurzius
Independent Chairman of the Board
Stacey Ma
Director
Kapila Kapur Anand
Independent Director
John P. Bilbrey
Independent Director
William F. Doyle
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US28414H1032
  • Market cap
    $5.95bn
  • Employees
    9,300
  • Shares in issue
    494.35m
  • Exchange
    New York Stock Exchange
  • Index
    TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.